PETS

BANFIELD FOUNDATION RELEASES 2023 IMPACT REPORT CELEBRATING $3.3 MILLION TO HELP REMOVE BARRIERS TO CARE AND MOBILIZE VETERINARY TEAMS

Retrieved on: 
Wednesday, March 20, 2024
Medicine, HOPE, Human, Humane society, Partnership, Associate, Mars, The Parker Project, Corporate Affairs, Transport, Food, Veterinarian, Michigan Humane, MAP, City, Dog, Banfield Pet Hospital, Navajo Nation, Heart, PETS, Pet, Cat, Vaccine, PAWS Chicago, Ambassador, Birth control

VANCOUVER, Wash., March 20, 2024 /PRNewswire/ -- Banfield Foundation, a 501(c)(3) nonprofit organization and the charitable arm of Banfield Pet Hospital®, today released its 2023 annual Impact Report detailing how $3.3 million in grants helped mobilize veterinary care, deploy veterinary teams and enable disaster relief.

Key Points: 
  • The 2023 report outlines how the Banfield Foundation meaningfully delivered on its mission of making preventive care possible for the pets that need it most.
  • Some of this care was delivered through the donation of six mobile veterinary units to nonprofit partners, totaling more than $750,000 in support.
  • In 2023 alone, nearly 65 veterinarians and veterinary technicians volunteered 3,450 hours with the Banfield Foundation caring for vulnerable dogs and cats.
  • "Our work is only possible because of the incredible teams of veterinary professionals that help deliver on that care.

PetMeds® to Give Away Free Pet Food for a Year to Three Lucky Pet Owners and $1,000 in PetMeds® Credits to Three Local Animal Shelters

Retrieved on: 
Friday, February 16, 2024
PetMed Express, Animal, PETS

Those three winners will also get to select a pet shelter of their choice to receive a $1,000 credit to petmeds.com .

Key Points: 
  • Those three winners will also get to select a pet shelter of their choice to receive a $1,000 credit to petmeds.com .
  • The giveaway will be open for entries on petmeds.com between February 16 and March 15, 2024.
  • The promotion comes in advance of Hill’s Science Diet products being available through petmeds.com, beginning March 1, 2024.
  • PetMeds® is doing its part to help promote responsible pet ownership by providing top-quality pet food and helping to ease the burden on animal shelters.

PetMed Express Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q

Retrieved on: 
Thursday, February 15, 2024
PetMed Express, Restatement, Calendar, Form, Notice, PETS, Cryptocurrency

The Notice has no immediate effect on the listing or trading of the Company’s common stock on Nasdaq.

Key Points: 
  • The Notice has no immediate effect on the listing or trading of the Company’s common stock on Nasdaq.
  • On February 9, 2024, the Company filed a Notification of Late Filing on Form 12b-25 indicating that it was unable, without unreasonable effort or expense, to file its Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2023 (the “Form 10-Q”) by the prescribed due date as a result of the restatement of certain of the Company’s financial statements (the “Restatement”).
  • The Restatement is more fully described in the Company’s Current Report on Form 8-K filed with the SEC on February 8, 2024.
  • While the Company can provide no assurances as to timing, the Company is working diligently to complete the Restatement and plans to file the Form 10-Q as soon as practicable to regain compliance with the Listing Rule.

PetMeds® Announces Selected Preliminary Third Quarter Financial Results

Retrieved on: 
Thursday, February 8, 2024
Report, PetMed Express, Audit committee, Acquisition, RSM US, History, Growth, GAAP, Net income, Cost, Annual report, Bank statement, Webcast, PETS, LLP, WalletHub, RSM, Parent, Cryptocurrency

DELRAY BEACH, Fla., Feb. 08, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: PETS) (“PetMeds” or the “Company”), Your Trusted Pet Health ExpertTM, today announced its selected preliminary financial results for its third quarter ended December 31, 2023.

Key Points: 
  • DELRAY BEACH, Fla., Feb. 08, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: PETS) (“PetMeds” or the “Company”), Your Trusted Pet Health ExpertTM, today announced its selected preliminary financial results for its third quarter ended December 31, 2023.
  • These preliminary financial results are unaudited, based on currently available information and do not present all necessary information for a complete understanding of the Company’s financial condition as of December 31, 2023 or its results of operations for the quarter ended December 31, 2023.
  • Gross margin improved to 27.4% in the quarter ended December 31, 2023 from 25.9% in the prior year period.
  • This afternoon the Company will host a conference call to review selected preliminary third quarter financial results.

PetMed Express, Inc. Sets Fiscal Third Quarter 2024 Earnings Call

Retrieved on: 
Monday, January 29, 2024
PetMed Express, PETS

DELRAY BEACH, Fla., Jan. 29, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (Nasdaq: PETS) (the “Company”), Your Trusted Pet Health ExpertTM will hold a conference call on Thursday, February 8, 2024 at 4:30pm Eastern time to discuss its financial results for the fiscal third quarter ended December 31, 2023.

Key Points: 
  • DELRAY BEACH, Fla., Jan. 29, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (Nasdaq: PETS) (the “Company”), Your Trusted Pet Health ExpertTM will hold a conference call on Thursday, February 8, 2024 at 4:30pm Eastern time to discuss its financial results for the fiscal third quarter ended December 31, 2023.
  • Financial results will be issued in a press release prior to the call.
  • If you have any difficulty connecting with the conference call, please contact MZ Group at 561-374-0177.
  • A telephonic replay of the conference call will also be available after 7:30 PM Eastern time on the same day through February 22, 2024.

PetMeds® Announces new Chairman of the Board

Retrieved on: 
Monday, January 8, 2024
PetMed Express, PETS, Audit, Senior management, Growth, Compensated emancipation, Committee, Corporate governance, Management

DELRAY BEACH, Fla., Jan. 8, 2024 /PRNewswire/ -- PetMed Express, Inc. ("PetMeds®") (NASDAQ: PETS), Your Trusted Pet Health Expert™, announces the appointment of Leslie C. G. Campbell as Chairman of the Board effective January 5, 2024, as part of the company's ongoing Board composition and succession planning.

Key Points: 
  • DELRAY BEACH, Fla., Jan. 8, 2024 /PRNewswire/ -- PetMed Express, Inc. ("PetMeds®") (NASDAQ: PETS), Your Trusted Pet Health Expert™, announces the appointment of Leslie C. G. Campbell as Chairman of the Board effective January 5, 2024, as part of the company's ongoing Board composition and succession planning.
  • As Chairman, Ms. Campbell succeeds Dr. Gian Fulgoni, who will remain a member of the Board and its various committees and continue to chair the Board's Corporate Governance and Nominating Committee.
  • "I am deeply honored to be appointed Chairman of the PetMed Express Board of Directors," said Campbell.
  • "It has been an honor to have served as Chairman of PetMed Express for the last three years," said Dr. Fulgoni.

PetMed Express, Inc.: Company Investigated by the Portnoy Law Firm

Retrieved on: 
Tuesday, December 19, 2023
PETS, PetMed Express

LOS ANGELES, Dec. 19, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS) investors that the firm has initiated an investigation into possible securities violations and may file a class action on behalf of investors. PetMed investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq.

Key Points: 
  • LOS ANGELES, Dec. 19, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS) investors that the firm has initiated an investigation into possible securities violations and may file a class action on behalf of investors.
  • PetMed investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq.
  • The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
  • The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing.

PetMed Express, Inc.: Company Investigated by the Portnoy Law Firm

Retrieved on: 
Friday, December 8, 2023
PETS, PetMed Express

LOS ANGELES, Dec. 08, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS) investors that the firm has initiated an investigation into possible securities violations and may file a class action on behalf of investors. PetMed investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq.

Key Points: 
  • LOS ANGELES, Dec. 08, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS) investors that the firm has initiated an investigation into possible securities violations and may file a class action on behalf of investors.
  • PetMed investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq.
  • The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
  • The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS

Retrieved on: 
Monday, December 4, 2023
LLP, PETS, PetMed Express, News, Pomerantz

NEW YORK, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS).

Key Points: 
  • NEW YORK, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS).
  • Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext.
  • The investigation concerns whether PetMed and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of PetMed Express, Inc. - PETS

Retrieved on: 
Tuesday, November 21, 2023
LLP, PETS, PetMed Express, News, Pomerantz, Prior

NEW YORK, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS).

Key Points: 
  • NEW YORK, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS).
  • Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext.
  • The investigation concerns whether PetMed and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.